SCHEMBL19121964

SCHEMBL19121964

CC(S)c1ncnn1C(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11967315 0.82 PIK3CA (0.30) —
SCHEMBL20556654 0.78 PIK3CA (0.32) —
SCHEMBL11836639 0.73 — —
SCHEMBL15357762 0.72 — —
SCHEMBL15357775 0.72 — —
SCHEMBL21212490 0.70 — —
SCHEMBL15357763 0.69 — —
SCHEMBL21149317 0.67 KDM4E (0.33) —
SCHEMBL21924892 0.67 — —
SCHEMBL17768671 0.65 PIK3CD (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170196862-A2 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2017-07-13 — — US disclosed
Send feedback